These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 27317359)

  • 1. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microbial amino acid metabolism in host metabolism.
    Neis EP; Dejong CH; Rensen SS
    Nutrients; 2015 Apr; 7(4):2930-46. PubMed ID: 25894657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin hormones, obesity and gut microbiota.
    Angelini G; Russo S; Mingrone G
    Peptides; 2024 Aug; 178():171216. PubMed ID: 38636809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus.
    Allin KH; Nielsen T; Pedersen O
    Eur J Endocrinol; 2015 Apr; 172(4):R167-77. PubMed ID: 25416725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    Caesar R; Fåk F; Bäckhed F
    J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of gut microbiota on subclinical inflammation and insulin resistance.
    Carvalho BM; Saad MJ
    Mediators Inflamm; 2013; 2013():986734. PubMed ID: 23840101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.